Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PhenixFIN (PFX) Cash & Equivalents (2021 - 2026)

PhenixFIN has reported Cash & Equivalents over the past 5 years, most recently at $3.4 million for Q4 2025.

  • Quarterly Cash & Equivalents fell 52.6% to $3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2025, down 52.6% year-over-year, with the annual reading at $7.3 million for FY2025, 89.21% down from the prior year.
  • Cash & Equivalents was $3.4 million for Q4 2025 at PhenixFIN, down from $7.3 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $69.4 million in Q3 2021 and troughed at $3.4 million in Q4 2025.
  • The 5-year median for Cash & Equivalents is $11.5 million (2023), against an average of $22.3 million.
  • Year-over-year, Cash & Equivalents surged 1028.41% in 2024 and then plummeted 89.21% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $59.4 million in 2021, then plummeted by 70.27% to $17.7 million in 2022, then plummeted by 31.04% to $12.2 million in 2023, then tumbled by 40.96% to $7.2 million in 2024, then tumbled by 52.6% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for PFX's Cash & Equivalents are $3.4 million (Q4 2025), $7.3 million (Q3 2025), and $7.3 million (Q2 2025).